Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Postreperfusion Syndrome”

7 trials

Showing 7 of 7 results

Very early researchStudy completedNCT05277623
What this trial is testing

Effect of Mannitol on Postreperfusion Syndrome During Living Donor Liver Transplant

Who this might be right for
Liver Transplant Disorder
Ain Shams University 60
Post-approval studies (Phase 4)Study completedNCT01001403
What this trial is testing

Effect of Nafamostat on Postreperfusion Syndrome (PRS)

Who this might be right for
Liver TransplantationPostreperfusion Syndrome
Seoul National University Hospital 62
Post-approval studies (Phase 4)Study completedNCT01886664
What this trial is testing

Comparison of PRS According to Inhalation Agent During LDLT

Who this might be right for
Liver TransplantationPostreperfusion Syndrome
Seoul National University Hospital 70
Not applicableStudy completedNCT05658120
What this trial is testing

Reperfusion Syndrome and Vasoplegic Syndrome in Liver Transplant Surgery

Who this might be right for
Postperfusion Syndrome
Hospital Universitari Vall d'Hebron Research Institute 246
Testing effectiveness (Phase 2)Study completedNCT03773276
What this trial is testing

Norepinephrine Boluses in Liver Transplantation

Who this might be right for
Living Donor Liver TransplantationNorepinephrine BolusPostperfusion Syndrome
Mansoura University 40
Not applicableStudy completedNCT01080625
What this trial is testing

Effect of Epinephrine/ Phenylephrine for Preventing the Postreperfusion Syndrome During Reperfusion in Liver Transplantation

Who this might be right for
Hypotension After Reperfusion in Liver Transplantation
Seoul National University Hospital 96
Testing effectiveness (Phase 2)UnknownNCT05754242
What this trial is testing

Ascorbic Acid to Prevent Postreperfusion Syndrome in Liver Transplantation

Who this might be right for
Liver TransplantationPostreperfusion SyndromeAscorbic Acid
Hospital Universitario Ramon y Cajal 70

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation